Strategies for prevention of scars: What can we learn from fetal skin?

International Journal of Dermatology

Volumn 50, Issue 1, 2011, Pages 85-93

  Namazi, Mohammad Reza ^a   Fallahzadeh, Mohammad Kazem ^b   Schwartz, Robert A ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DECORIN; DIPEPTIDYL CARBOXYPEPTIDASE; FIBROBLAST GROWTH FACTOR; FIBROMODULIN; HOX PROTEIN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; ONION EXTRACT; PLATELET DERIVED GROWTH FACTOR; PROTEIN LYSINE 6 OXIDASE; SCARGUARD MD; SEPRAFILM BIORESORBABLE MEMBRANE; SILICONE GEL; TAMOXIFEN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; WOUND HEALING PROMOTING AGENT;

ARTICLE; CELL SHAPE; CELL STRUCTURE; FETUS; FETUS DEVELOPMENT; FIBROBLAST; GENE; GROUPS BY AGE; HUMAN; HYPOXIA; INFLAMMATION; MYOFIBROBLAST; PERINATAL PERIOD; PULSED DYE LASER; SCAR FORMATION; WOUND HEALING;

ANOXIA; CICATRIX; COLLAGEN; DECORIN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; FIBROBLASTS; GENES, HOMEOBOX; HUMANS; HYALURONIC ACID; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASES; PROTEIN-LYSINE 6-OXIDASE; PROTEOGLYCANS; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASES; WOUND HEALING;

EID: 78650548314     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04678.x     Document Type: Article

References (64)

1. Rumsey N, Clarke A, White P. Exploring the psychosocial concerns of outpatients with disfiguring conditions. J Wound Care 2003; 12: 247-252.
2. Colwell A, Longaker M, Lorenz PH. Fetal wound healing. In: Falabella AF, Kirsner RS, eds. Wound Healing. Boca Raton: Taylor & Francis, 2005: 9-16.
3. Lorenz HP, Whitby DJ, Longaker MT, et al. Fetal wound healing: the ontogeny of scar formation in the non-human primate. Ann Surg 1993; 217: 391-396.
4. Lorenz HP, Lin RY, Longaker MT, et al. The fetal fibroblast: the effector cell of scarless wounds repair. Plast Reconst Surg 1995; 96: 1251-1259.
5. Longaker MT, Whitby DJ, Jennings RW, et al. Fetal diaphragmatic wounds heal with scar formation. J Surg Res 1991; 50: 375-385.
6. Mast BA, Albanese CT, Kapadia S. Tissue repair in the fetal intestinal tract occurs with adhesions, fibrosis, and neovascularization. Ann Plast Surg 1998; 41: 140-144; discussion 144-147.
7. Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 1990; 25: 63-68; discussion 68-69.
8. Armstrong JR, Ferguson MWJ. Ontogeny of the skin and transition from scar free to scarring phenotype during wound healing in the pouch young of Monodelphis domestica. Dev Biol 1995; 169: 242-260.
9. Longaker MT, Whitby DJ, Ferguson MWJ, et al. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg 1994; 219: 65-72.
10. Whitby DJ, Ferguson MW. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 1991; 112: 651-668.
11. Hallock GG, Merkel JR, Rice DC, DiPaolo BR. The ontogenetic transition of collagen deposition in rat skin. Ann Plastic Surg 1993; 30: 239-243.
12. Dasgeb B, Phillips TJ. What are scars? In: Arndt KA, ed. Scar Revision. Philadelphia: Elsevier, Saunders, 2006: 1-16.
13. Balazs EA, Larsen NE. Hyaluronan: aiming for perfect skin regeneration. In: Garg HG, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker, 2000: 143-161.
14. Shah M, Rorison P, Ferguson MWJ. The role of transforming growth factors-beta in cutaneous scarring. In: Garg HG, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker, 2000: 213-227.
15. Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Science 1995; 108: 985-1002.
16. Hsu M, Peled ZM, Chin GS, et al. Ontogeny of expression of transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 3, and TGF-beta receptors I and II in fetal rat fibroblasts and skin. Plast Reconstr Surg 2001; 107: 1787-1794.
17. Eslami A, Gallant-Behm CL, Hart DA, et al. Expression of integrin αvβ6 and TGF-β in scarless vs scar-forming wound healing. J Histochem Cytochem 2009; 57: 543-557.
18. Rolfe KJ, Richardson J, Vigor C, et al. A role for TGF-beta1-induced cellular responses during wound healing of the non-scarring early human fetus? J Invest Dermatol 2007; 127: 2656-2667.
19. Lorenz V, Soo C, Beanes SR, et al. Differential expression of matrix metalloproteinases and their tissue derived inhibitors in scarless fetal wound healing. Surg Forum 2001; 52: 397-401.
20. Yang GP, Lim IJ, Phan T-T, et al. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Rep Reg 2003; 11: 411-418.
21. Scheid A, Wenger RH, Schäffer L, et al. Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3. FASEB J 2002; 16: 411-413.
22. Estes JM, Vande Berg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994; 56: 173-181.
23. Cass DL, Sylvester KG, Yang EY, et al. Myofibroblast persistence in fetal sheep wounds is associated with scar formation. J Pediatr Surg 1997; 32: 1017-1021.
24. Liu W, Cao Y, Longaker MT. Gene therapy of scarring: a lesson learned from fetal scarless wound healing. Yonsei Med J 2001; 42: 634-645.
25. Kong W, Li S, Longaker MT, Lorenz HP. Blood-derived small Dot cells reduce scar in wound healing. Exp Cell Res 2008; 314: 1529-1539.
26. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 2000; 12: 671-676.
27. Liechty KW, Crombleholme TM, Cass DL, et al. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 1998; 77: 80-84.
28. Gordon AD, Karmacharya J, Herlyn M. Scarless wound healing induced by adenoviral-mediated overexpression of interleukin-10. Surg Forum 2001; 52: 568-569.
29. Bender BG, Ballard R, Canono B, et al. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 2008; 58: 415-420.
30. Morihara K, Takai S, Takenaka H, et al. Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin. J Am Acad Dermatol 2006; 54: 251-257.
31. Namazi H. ACE inhibitors: a novel treatment for neurofibroma. Ann Surg Oncol 2008; 15: 1538-1539.
32. Chin GS, Stelnicki EJ, Gittes GK, Longaker MT. Characteristics of fetal wound repair. In: Garg HG, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker, 2000: 239-263.
33. Jain K, Sykes V, Kordula T, et al. Homeobox genes Hoxd3 and Hoxd8 are differentially expressed in fetal mouse excisional wounds. J Surg Res 2008; 148: 45-48.
34. Berman B, Zell D. Medical treatment of scarring. In: Arndt KA, ed. Scar Revision, 1st edn. China: Elsevier, Saunders, 2006: 1-16.
35. Ashcroft GS, Horan MA, Herrick SE, et al. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res 1997; 290: 581-591.
36. Ashcroft GS, Herrick SE, Tarnuzzer RW, et al. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol 1997; 183: 169-176.
37. Bender O, Balci FL, Yüney E, et al. Scarless endoscopic papillomectomy of the breast. Onkologie 2009; 32: 94-98.
38. Wolfram D, Tzankov A, Pülzl P, et al. Hypertrophic scars and keloids - a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 2009; 35: 171-181.
39. Chang CC, Kuo YF, Chiu HC, et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 1995; 59: 705-711.
40. Falabella CA, Melendez MM, Weng L, et al. Novel macromolecular crosslinking hydrogel to reduce intra-abdominal adhesions. J Surg Res 2010; 159: 772-778.
41. Fujii S, Shimada H, Ike H, et al. Reduction of postoperative abdominal adhesion and ileus by a bioresorbable membrane. Hepatogastroenterology 2009; 56: 725-728.
42. Emre A, Akin M, Isikgonul I, et al. Comparison of intraperitoneal honey and sodium hyaluronate-carboxymethylcellulose (Seprafilm) for the prevention of postoperative intra-abdominal adhesions. Clinics (Sao Paulo) 2009; 64: 363-368.
43. Kawamura YJ, Kakizawa N, Tan KY, et al. Sushi-roll wrap of Seprafilm for ileostomy limbs facilitates ileostomy closure. Tech Coloproctol 2009; 13: 211-214.
44. Mast BA, Flood LC, Haynes JH, et al. Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Matrix 1991; 11: 63-68.
45. McCarty MF. Glucosamine for wound healing. Med Hypotheses 1996; 47: 273-275.
46. Rhett JM, Ghatnekar GS, Palatinus JA, et al. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 2008; 26: 173-180.
47. Chang J, Siebert JW, Schendel DA, et al. Scarless wound healing: implications for the aesthetic surgeon. Aesthetic Plast Surg 1995; 19: 237-241.
48. Wang Z, Gao Z, Shi Y, et al. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007; 60: 1193-1199.
49. Ruffy MB, Kunnavatana SS, Koch RJ. Effects of tamoxifen on normal human dermal fibroblasts. Arch Facial Plast Surg 2006; 8: 329-332.
50. Morena AM, Oshima CT, Gebrim LH, et al. Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma. Neoplasma 2004; 51: 481-486.
51. Nouri K, Jimenez GP, Harrison-Balestra C, et al. 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day. Dermatol Surg 2003; 29: 65-73; discussion 73.
52. Lee DH, Choi YS, Min SU, et al. Comparison of a 585-nm pulsed dye laser and a 1064-nm Nd:YAG laser for the treatment of acne scars: a randomized split-face clinical study. J Am Acad Dermatol 2009; 60: 801-807.
53. Sherris DA, Gassner HG. Botulinum toxin to minimize facial scarring. Facial Plast Surg 2002; 18: 35-39.
54. Xiao Z, Zhang F, Cui Z. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg 2009; 33: 409-412.
55. Draelos ZD. The ability of onion extract gel to improve the cosmetic appearance of postsurgical scars. J Cosmet Dermatol 2008; 7: 101-104.
56. Berman B, Frankel S, Villa AM, et al. Double-blind, randomized, placebo-controlled, prospective study evaluating the tolerability and effectiveness of imiquimod applied to postsurgical excisions on scar cosmesis. Dermatol Surg 2005; 31: 1399-1403.
57. Baumann LS, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg 1999; 25: 311-315.
58. Wilgus TA, Vodovotz Y, Vittadini E, et al. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair Regen 2003; 11: 25-34.
59. Blomme EA, Chinn KS, Hardy MM, et al. Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice. Br J Dermatol 2003; 148: 211-223.
60. Ledo E, de las Heras ME, Ledo A. Treatment for acute radiodermatitis with Cryptomphalus aspersa secretion. Radioprotección 1999; 23.
61. Brieva A, Philips N, Tejedor R, et al. Molecular basis for the regenerative properties of a secretion of the mollusk Cryptomphalus aspersa. Skin Pharmacol Physiol 2008; 21: 15-22.
62. Cohen JL, Jorizzo JL, Kircik LH. Use of a topical emulsion for wound healing. J Support Oncol 2007; 5: 1-9.
63. De Rauglaudre G, Courdi A, Delaby-Chagrin F, et al. Tolerance of the association sucralfate/Cu-Zn salts in radiation dermatitis. Ann Dermatol Venereol 2008; Spec No 1: 11-15.
64. Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997; 3: 1209-1215.